Other Income & Expense
Other Charges
Regeneron Pharmaceuticals Other Charges increased by 14.3% to $201.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 37.5%, from $322.00M to $201.20M. Over 3 years (FY 2022 to FY 2025), Other Charges shows an upward trend with a 111.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
How to read this metric
An increase suggests unexpected non-operating costs or one-time financial hits, which can negatively impact net income.
Detailed definition
This metric captures non-operating financial expenses that do not fall under standard categories like interest or taxes....
Peer comparison
Often found in the non-operating section of the income statement; peers may label these as 'other expenses' or 'sundry charges'.
Metric ID:
hon_other_chargesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $420.00M | -$16.40M | -$183.80M | -$133.60M | $301.40M | $195.30M | -$70.70M | $85.30M | $17.60M | $193.00M | -$34.60M | $573.30M | $327.30M | $0.00 | $322.00M | $442.80M | $755.80M | $176.00M | $201.20M |
| QoQ Change | — | -103.9% | <-999% | +27.3% | +325.6% | -35.2% | -136.2% | +220.7% | -79.4% | +996.6% | -117.9% | >999% | -42.9% | -100.0% | — | +37.5% | +70.7% | -76.7% | +14.3% |
| YoY Change | — | — | — | -131.8% | >999% | — | +61.5% | +163.8% | -94.2% | -1.2% | +51.1% | +572.1% | >999% | -100.0% | >999% | -22.8% | +130.9% | — | -37.5% |
Range-$183.80M – $755.80M
CAGR-15.1%
Avg YoY Growth+380.0%
Median YoY Growth+56.3%
Other Charges at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's other charges?
- Regeneron Pharmaceuticals (REGN) reported other charges of $201.20M in Q1 2026.
- How has Regeneron Pharmaceuticals's other charges changed year-over-year?
- Regeneron Pharmaceuticals's other charges decreased by 37.5% year-over-year, from $322.00M to $201.20M.
- What is the long-term trend for Regeneron Pharmaceuticals's other charges?
- Over 3 years (2022 to 2025), Regeneron Pharmaceuticals's other charges has grown at a 111.5% compound annual growth rate (CAGR), from $179.30M to $1.70B.
- What does other charges mean?
- Miscellaneous non-operating financial expenses not classified elsewhere.